Getting A Vaccine To Market: The Timeline, The Process, And What To Expect
Source: Altasciences
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses the drug and vaccine development process to provide insight on the typical timelines for getting a vaccine to market.
Specifically, Setnik touches on some of the issues experienced around COVID and expands on several challenges, such as determining whether a potential vaccine or a treatment is safe and effective, in addition to how manufacturing can be leveraged for widespread availability.
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Altasciences
This website uses cookies to ensure you get the best experience on our website. Learn more